Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan C Short

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Cancers|April 13, 2024
Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling StudyKavi Fatania, Russell Frood, Hitesh Mistry, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 27, 2023
The experience of interval scans for adults living with primary malignant brain tumorsFlorien W Boele, Sarah E Rudkin, Kate Absolom, et al.
European Radiology|November 28, 2024
Impact of intensity standardisation and ComBat batch size on clinical-radiomic prognostic models performance in a multi-centre study of patients with glioblastomaKavi Fatania, Russell Frood, Hitesh Mistry, et al.
Palliative Medicine|February 3, 2023
Communication in the context of glioblastoma treatment: A qualitative study of what matters most to patients, caregivers and health care professionalsFlorien W Boele, Sean Butler, Emma Nicklin, et al.
British Journal of Cancer|February 24, 2021
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastomaChris Twelves, Michael Sabel, Daniel Checketts, et al.
Neuro-Oncology Practice|January 28, 2022
Long-term impact of adult WHO grade II or III gliomas on health-related quality of life: A systematic reviewSé Maria Frances, Galina Velikova, Martin Klein, et al.
European Radiology|April 29, 2022
Intensity standardization of MRI prior to radiomic feature extraction for artificial intelligence research in glioma-a systematic reviewKavi Fatania, Farah Mohamud, Anna Clark, et al.
Neuro-Oncology|October 11, 2017
Selective BCL-XL inhibition promotes apoptosis in combination with MLN8237 in medulloblastoma and pediatric glioblastoma cellsJane Levesley, Lynette Steele, Anke Brüning-Richardson, et al.
Clinical Endocrinology|October 27, 2015
Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumoursNikolaos Kyriakakis, Julie Lynch, Steve M Orme, et al.
Clinical Endocrinology|March 16, 2019
Hypothalamic-pituitary axis irradiation dose thresholds for the development of hypopituitarism in adult-onset gliomasNikolaos Kyriakakis, Julie Lynch, Steve M Orme, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Cancers|April 13, 2024
Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling StudyKavi Fatania, Russell Frood, Hitesh Mistry, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 27, 2023
The experience of interval scans for adults living with primary malignant brain tumorsFlorien W Boele, Sarah E Rudkin, Kate Absolom, et al.
European Radiology|November 28, 2024
Impact of intensity standardisation and ComBat batch size on clinical-radiomic prognostic models performance in a multi-centre study of patients with glioblastomaKavi Fatania, Russell Frood, Hitesh Mistry, et al.
Palliative Medicine|February 3, 2023
Communication in the context of glioblastoma treatment: A qualitative study of what matters most to patients, caregivers and health care professionalsFlorien W Boele, Sean Butler, Emma Nicklin, et al.
British Journal of Cancer|February 24, 2021
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastomaChris Twelves, Michael Sabel, Daniel Checketts, et al.
Neuro-Oncology Practice|January 28, 2022
Long-term impact of adult WHO grade II or III gliomas on health-related quality of life: A systematic reviewSé Maria Frances, Galina Velikova, Martin Klein, et al.
European Radiology|April 29, 2022
Intensity standardization of MRI prior to radiomic feature extraction for artificial intelligence research in glioma-a systematic reviewKavi Fatania, Farah Mohamud, Anna Clark, et al.
Neuro-Oncology|October 11, 2017
Selective BCL-XL inhibition promotes apoptosis in combination with MLN8237 in medulloblastoma and pediatric glioblastoma cellsJane Levesley, Lynette Steele, Anke Brüning-Richardson, et al.
Clinical Endocrinology|October 27, 2015
Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumoursNikolaos Kyriakakis, Julie Lynch, Steve M Orme, et al.
Clinical Endocrinology|March 16, 2019
Hypothalamic-pituitary axis irradiation dose thresholds for the development of hypopituitarism in adult-onset gliomasNikolaos Kyriakakis, Julie Lynch, Steve M Orme, et al.
Pageof 8